Showing results (41-50 of 198) with videos related to
Sort By:
Pageof 20
Frontiers in Molecular Neuroscience|February 15, 2019
Neuroblastoma-A Neural Crest Derived Embryonal MalignancyJohn Inge Johnsen, Cecilia Dyberg, Malin WickströmProceedings of the National Academy of Sciences of the United States of America|October 23, 2009
Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cellsHiromi Hanaka, Sven-Christian Pawelzik, John Inge Johnsen, et al.Developmental Cell|January 27, 2016
The 1p36 Tumor Suppressor KIF 1Bβ Is Required for Calcineurin Activation, Controlling Mitochondrial Fission and ApoptosisShuijie Li, Stuart M Fell, Olga Surova, et al.Cell Reports. Medicine|June 10, 2022
The immune cell atlas of human neuroblastomaBronte Manouk Verhoeven, Shenglin Mei, Thale Kristin Olsen, et al.Current Oncology Reports|April 1, 2022
Neuroblastoma Heterogeneity, Plasticity, and Emerging TherapiesKristina Ihrmark Lundberg, Diana Treis, John Inge JohnsenCancer Letters|September 22, 2024
The ROCK-1/2 inhibitor RKI-1447 blocks N-MYC, promotes cell death, and emerges as a synergistic partner for BET inhibitors in neuroblastomaAdena Pepich, Conny Tümmler, Sara Abu Ajamieh, et al.Advances in Cancer Research|April 20, 2010
MYC in oncogenesis and as a target for cancer therapiesAmi Albihn, John Inge Johnsen, Marie Arsenian HenrikssonOncotarget|January 17, 2012
Is human cytomegalovirus a target in cancer therapy?John Inge Johnsen, Ninib Baryawno, Cecilia Söderberg-NauclérCell Death & Disease|April 19, 2025
Targeted inhibition of WIP1 and histone H3K27 demethylase activity synergistically suppresses neuroblastoma growthDiana Treis, Kristina Ihrmark Lundberg, Nicola Bell, et al.Cell Reports|July 12, 2016
Regulation of Nuclear Hormone Receptors by MYCN-Driven miRNAs Impacts Neural Differentiation and Survival in Neuroblastoma PatientsDiogo Ribeiro, Marcus D R Klarqvist, Ulrica K Westermark, et al.Pageof 20